Subscribe to MOIL (Manganese Ore India) IPO at upper price band of 375 (340-375); issue opens on Nov 26. Can easily list at 440. Remember retail segment limit has been raised to Rs 200000/- now.
Avoid the CLARIS IPO, also opening on Nov 26 at a price band of 278-293. The management integirity is suspect. They have defaulted on lot of loans and their products have also been under the scanner. On May 29, 2010, the U.S. Food and Drug Administration (FDA) alerted healthcare professionals not to use certain intravenous bags of metronidazole, ondansetron, and ciprofloxacin because of potential contamination. FDA has received reports of floating matter in IV bags manufactured by Claris Lifesciences Limited, in Ahmedabad, India.
The company as earlier called Core Healthcare and you can read about its management (current promoter is the son of Sushil Handa) from this link (http://nse2rich.com/?qoOJjYm2).
No comments:
Post a Comment